Latest News:  
Beijing   Thundershower/Overcast    28 / 22 ℃  City Forecast

Home>>China Society

Shanghai scientists may have found AIDS vaccine

(Shanghai Daily)

14:32, July 12, 2012

Shanghai scientists are claiming a breakthrough in the search for an HIV vaccine, with clinical trials on humans expected to begin in three years' time, given sufficient funding.

Scientists from the Institut Pasteur of Shanghai, Chinese Academy of Sciences, say they are the first in the world to use fruit fly cells to produce HIV-1 virus-like particles which then successfully generated immunity in mice.

The HIV-1 virus is the most common strain of HIV viruses.

The scientists' research has been published in the leading Journal of Virology.

Currently, there is no effective treatment for HIV/AIDS. Medicines can only control duplication of the virus, not kill it.

Thus, a safe and effective vaccine is of vital importance if the spread of HIV/AIDS is to be controlled.

However, previous research into HIV vaccines has not gone smoothly.

In 2009, an experimental HIV vaccine developed in Thailand for the first time cut the risk of contracting HIV by 31 percent in humans after failed trials in previous years.

"But that vaccine can't be used for wide-scale injection on humans due to its low protection rate and poor effects on virus load reduction," said Paul Zhou, leading scientist in the Shanghai discovery.

"Concerning the previous researches on HIV vaccine, we decided to stick to the production of HIV virus-like particles," he said.

Virus-like particles resemble viruses, but are non-infectious because they do not contain any viral genetic material.

So far, VLPs have been successfully developed into vaccines for the prevention of infection by the hepatitis B virus (HBV) and the human papilloma virus (HPV), the cause of cervical cancer.

Zhou said that current methods of producing HIV-1 VLPs had many limitations but his team developed a novel strategy to produce them using fruit fly cells.

In the laboratory, mice injected with the HIV-1 VLP developed an immunity against the HIV virus.

Zhou said his team's method of producing the VLPs boded well for the development of a vaccine against HIV-1.

"In the next step, we will do tests on monkeys.

"The success of monkeys will pave the way for clinical trials on human beings."

Email|Print|Comments(Editor:马茜、姚春)

Leave your comment0 comments

  1. Name

  

Selections for you


  1. Bayi Aerobatic Team of PLA Air Force stages air show in Xi'an

  2. Piranha 'wanted' as controversial manhunt kicks off

  3. Experiencing unique Taoist culture in Wudang

  4. Ten fruits that help moisture skin

  5. Congressional Gold Medal Ceremony in Honor of Constantino Brumidi

  6. Companies have home thoughts from abroad

Most Popular

Opinions

  1. Naval exercises routine, not warning to Japan
  2. Hanoi will feel pain for helping US return
  3. Cooperation keeps China-Africa ties strong
  4. China won't yield to Japan's moves over disputes
  5. Sea spat can draw mainland and Taiwan closer
  6. New regulations a chance to build clean govt
  7. Negotiations on COC in S. China Sea favor peace
  8. Hanoi will feel pain for helping US return
  9. Telecoms industry stifled by capital prohibition
  10. Socialist market economy turning point for China

What's happening in China

McDonald's, Coca-Cola's Olympic sponsorship questioned

  1. Brand of instant noodles too acidic
  2. Foreign man stabbed to death in Beijing
  3. Farmer battles govt for wood
  4. Guangzhou doctors offer free surgeries
  5. TV channel suspended for showing porn

China Features

  1. Why is TCM worth of commendation?
  2. Arabians pay heavy price for Arab Spring
  3. Master of pasted-paper sculpture
  4. China, US hold mixed attitudes toward each other
  5. China does not lack capital: CSRC Chair

PD Online Data

  1. Spring Festival
  2. Chinese ethnic odyssey
  3. Yangge in Shaanxi
  4. Gaoqiao in Northern China
  5. The drum dance in Ansai